MohammadMehdiAnsariMD
[Pronunciation: Mac Ansari, MD]
Cardiology • Lubbock, TXInterventional Cardiology
Vice Chair (CR) , Cardiac Cath Lab Director
Dr. Ansari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 4th St
Lubbock, TX 79430Phone+1 806-743-1501Fax+1 806-743-1183
Education & Training
University of Michigan HealthAdvance Vascular And Innovation, Fellowship, 2015 - 2016- Lenox Hill Heart And Vascular Institute, Zucker School of MedicineStructural And Congenital Heart Disease, Fellowship, 2014 - 2015
University of Miami/Jackson Health SystemFellowship, Interventional Cardiology, 2013 - 2014
New York Presbyterian Hospital (Cornell Campus)Fellowship, Cardiovascular Disease, 2010 - 2013- Tufts University School of MedicineCardiovascular Research Fellowship, 2009 - 2010
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2006 - 2009
Dow University of Health SciencesClass of 2001
Certifications & Licensure
NY State Medical License 2010 - 2026
TX State Medical License 2019 - 2026
MI State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Endowed Professor Texas Tech - UMC, 2020
Publications & Presentations
PubMed
- 1 citationsFORWARD Study of GORE VIABAHN Balloon-Expandable Endoprostheses and Bare Metal Stents in the United States, European Union, United Kingdom, Australia, and New Zealand ...Melissa L Kirkwood, Ehrin J Armstrong, Mohammad M Ansari, Andrew Holden, Michel M P J Reijnen
JMIR Research Protocols. 2023-12-04 - 6 citationsPrimary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries.Hans van Overhagen, Masato Nakamura, Patrick J Geraghty, Sid Rao, Max Arroyo
Vascular Medicine. 2023-12-01 - 1 citationsAssociation between elevated CHA2DS2-VASC score and contrast-induced nephropathy among patients undergoing percutaneous coronary intervention: a systematic review and ...Gaspar Del Rio-Pertuz, Natnicha Leelaviwat, Poemlarp Mekraksakit, Juthipong Benjanuwattra, Kenneth Nugent
Acta Cardiologica. 2023-10-01
Abstracts/Posters
- [Board 002] Intra-Aortic Balloon Pump and Peripheral LVAD For Treatment of Cardiogenic Shock: Clinical and Outcomes ComparisonMohammad Ansari, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
- [Board 465] The Use of Atherectomy For the Treatment of Symptomatic Peripheral Vascular DiseaseMohammad Ansari, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
- [Board 496] Clinical and Procedural Outcomes in TAVR For Bicuspid Versus Tricuspid Aortic Valve StenosisMohammad Ansari, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/16/2019
Press Mentions
Studies Reveal Underrepresentation of Women and Hispanic Populations in PAD TreatmentMay 7th, 2024
Professional Memberships
- Associate
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
